Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Hospital POVISA
Vigo, EspañaPublications in collaboration with researchers from Hospital POVISA (36)
2023
-
Critical patients COVID-19 has changed the management and outcomes in the ICU after 1 year of the pandemic? A multicenter, prospective, observational study
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 70-78
-
The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912
2022
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
-
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
Brain Sciences, Vol. 12, Núm. 11
2021
-
COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation
PLoS ONE, Vol. 16, Núm. 6 June
-
Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
-
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group
Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415
-
Long-term Outcomes After Tracheostomy for COVID-19
Archivos de Bronconeumologia, Vol. 57, pp. 54-56
-
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter
Neurologia, Vol. 36, Núm. 5, pp. 346-352
-
Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients
British Journal of Anaesthesia
-
Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)
REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207
2020
-
A Comparative Study of Doppler Ultrasound against Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 313-318
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
-
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study
Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267
-
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502
-
Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323
-
One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Reply
Reumatologia Clinica
2019
-
Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Annals of Oncology, Vol. 30, pp. iv42-iv43